🇺🇸 FDA
Patent

US 11179384

Treatment of nonalcoholic fatty liver disease

granted A61KA61K31/473A61P

Quick answer

US patent 11179384 (Treatment of nonalcoholic fatty liver disease) held by TAKEDA GMBH expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TAKEDA GMBH
Grant date
Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/473, A61P, A61P1/16, A61P29/00